NF-κB-IN-14
NF-κB-IN-14 (compound 5e) significantly inhibits nitric oxide production in LPS-induced macrophages (IC50: 6.4 μM) . NF-κB-IN-14 disrupts the TLR4-MyD88 protein interaction, leading to the suppression of the NF-κB signaling pathway suppression. NF-κB-IN-14 reduces ear edema and inflammation in an atopic dermatitis mouse model[1].
Product Specifications
CAS Number
[3019972-01-8]
UNSPSC
12352005
Target
NF-κB; Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nf-κb-in-14.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(/C=C/CN2C=NC3=C(Cl)N=C(Cl)N=C23)C=C1
Molecular Formula
C15H12Cl2N4
Molecular Weight
319.19
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162004/NF-κB-IN-14-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162004/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NF-κB; TLR4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human Charged multivesicular body protein 2a (CHMP2A)
Recombinant Human Charged multivesicular body protein 2a (CHMP2A)
Recombinant Human Charged multivesicular body protein 2a (CHMP2A)
Recombinant Human Charged multivesicular body protein 2a (CHMP2A)
Recombinant Human Charged multivesicular body protein 2a (CHMP2A)